Prevalence of Thyroid Disorders in a tertiary care hospital in Saudi Arabia
Journal Selection & Submission Sample Work
Placing a Saudi hospital study of thyroid disease
Thyroid disorders — hypothyroidism, hyperthyroidism, autoimmune thyroiditis and thyroid nodules — are among the most common endocrine conditions seen in hospital practice, and they affect women considerably more often than men. Their frequency in any population depends on iodine status, autoimmunity, age structure and how actively thyroid function is tested. Hospital-based prevalence data from the Gulf region are valuable because they describe the case mix clinicians actually encounter and can inform screening and laboratory planning.
The manuscript in this sample, Prevalence of Thyroid Disorders in a Tertiary Care Hospital in Saudi Arabia, is such a study. Its keywords are thyroid disorders, prevalence, endocrine disorders, Saudi Arabia and thyroid disease epidemiology. The document is labelled as both a journal selection and a journal submission sample: it recommends where to send the paper and also explains what happens once the author decides.
Four journals, from regional medicine to molecular endocrinology
This report compares four journals rather than three, spanning the range from geographically targeted to scientifically broad.
- Saudi Medical Journal, published by the Armed Forces Hospital in Riyadh, publishes original work, epidemiology, public health and standards of health care. The supporting table describes it as very appropriate because of geographical relevance: it promotes hospital-based research from within the Kingdom and has published endocrine studies. Its examples are two national clinical guidelines, on liver transplantation and cochlear implantation.
- Journal of Clinical & Translational Endocrinology (Elsevier) publishes patient-oriented research across endocrinology, including thyroid disease, and welcomes regional studies that are methodologically sound. Its examples are thyroid-specific: histopathology of TERT-promoter-mutated indeterminate nodules, and whether ACR TI-RADS predicts malignancy risk in medullary thyroid cancer.
- BMC Endocrine Disorders (BioMed Central) is described as a strong candidate for prevalence-based studies with solid statistical reporting, encouraging open-access publication of local and regional health data.
- International Journal of Endocrinology (Hindawi, part of Wiley) is included to cover the endocrine system at genomic, molecular, biochemical and cellular levels.
A comparator that uses qualitative acceptance ratings
The comparator is reproduced below as reported in the sample. Values change over time and should be confirmed with each journal.
| Parameter | Saudi Med J | J Clin Transl Endocrinol | BMC Endocr Disord | Int J Endocrinol |
|---|---|---|---|---|
| Impact factor | about 1.1 | 4.2 | 2.8 | about 2.2 |
| Review duration | 2–3 months | about 6 weeks | median 63 days to first decision | about 30–45 days |
| Acceptance | moderate | moderate | moderate to high | high |
| APC | USD 1,000 (original/review); USD 500 (short formats) | USD 2,940 | USD 3,190 | USD 2,450 |
| Word count | 4,000 (original article) | 3,000–6,000 | no limit (typically 3,500–5,000) | 5,000 (research) |
Where journals do not publish rejection rates, the report says so — "not mentioned on journal website" — and offers a qualitative acceptance rating instead. This is more honest than quoting a percentage that cannot be sourced. All four are open access, so cost becomes a real differentiator; the Saudi Medical Journal's tiered charge, lower for clinical notes and brief reports, is unusual.
Regional visibility or international endocrine readership
The central decision is audience. The Saudi Medical Journal places the findings in front of clinicians and health planners in the Kingdom and the Gulf at the lowest reported cost, which suits a paper whose main value is local. The Journal of Clinical & Translational Endocrinology carries the highest reported impact factor and has recently published thyroid papers, but would expect the prevalence data to be analysed with enough depth to interest an international endocrine readership. BMC Endocrine Disorders is the explicit fit for regional prevalence studies with robust statistics. Pubrica's journal selection service prepares this kind of multi-journal comparison.
What the appendix says about the submission stage
The sample's appendix addresses practical questions rather than journal scope. It states plainly that no journal acceptance is guaranteed, since decisions rest with editors and peer reviewers. It explains that the report includes clarifications and one round of revision if requested within five working days, and that submission support can be purchased separately. It also confirms that submissions are made under the corresponding author's name and credentials, with Pubrica acting only as back-end support and not as a co-author or intermediary. Authors who want that next step handled can use the journal submission service, and manuscript formatting adapts the paper to the chosen journal. For the study itself, editors will expect STROBE-compliant reporting, clear definitions of each thyroid disorder and the laboratory reference ranges used.
Questions about this sample
Why does the Saudi thyroid report include the Saudi Medical Journal?
Its supporting table cites geographical relevance: the journal promotes hospital-based research from within the Kingdom of Saudi Arabia, focuses on health issues in Saudi Arabia and the Gulf, and has published endocrine-related studies. As reported in the sample, its charge for an original article is about USD 1,000, the lowest of the four options.
Why does the comparator use words like moderate and high instead of acceptance percentages?
None of the four journals published rejection rates on their websites when the report was prepared, so the sample records them as not mentioned and gives a qualitative acceptance rating instead. This avoids presenting unsourced figures as fact, though authors may still ask editorial offices for current statistics.
Which journal has recently published thyroid-specific research?
The Journal of Clinical & Translational Endocrinology. The report cites a 2024 study on TERT-promoter-mutated indeterminate thyroid nodules and a 2025 study on ACR TI-RADS and medullary thyroid cancer. As reported in the sample, it has the highest impact factor of the four, about 4.2.
Does Pubrica submit the manuscript under its own name?
No. The sample's appendix states that all submissions are made under the corresponding author's name and credentials. Pubrica provides back-end support only and does not appear as a co-author or intermediary. It also notes that journal acceptance cannot be guaranteed, as decisions rest with editors and reviewers.
Give yourself the academic edge today
Each order includes
- On-time delivery or your money back
- A fully qualified writer in your subject
- In-depth proofreading by our Quality Control Team
- 100% confidentiality, the work is never re-sold or published
- Standard 7-day amendment period
- A paper written to the standard ordered
- A detailed plagiarism report
- A comprehensive quality report
Enquire Now
